Abbott broadens EU marketing for cancer Dx; Boston hospital concocts quick release surgical tape;

 @FierceMedDev: Ariste Medical raised $1.275M in seed money to advance development of a drug-coated vascular graft. More | Follow @FierceMedDev

 @MarkHFierce: CryoLife celebrates 13% revenue jump in Q3. More | Follow @MarkHFierce

 @DamianFierce: Orthofix pays $32M to settle allegations it gave kickbacks--including parties with strippers & prostitutes--to docs. More | Follow @DamianFierce

> Abbott ($ABT) says it will expand the current product labeling for a non-small cell lung cancer test so it can be marketed in the European Union as a companion diagnostic. Item

> Parker Hannifin ($PH) will license exoskeleton device technology from Vanderbilt University and hopes to launch it commercially in 2014. Item

> Ariste Medical raised $1.275 million in seed money toward development of a drug-eluting vascular graft designed to prevent graft failure in hemodialysis patients. Item

> Tryton Medical presented robust data regarding 905 patients whose bifurcation lesions were treated with the company's side branch stent. Item

> Smiths Medical in Minnesota gained a CE mark for a new safety IV catheter for intravenous infusion. Release

> Brigham and Women's Hospital researchers came up with a quick-release surgical tape that sticks but is easy to remove--a crucial advance for neonatal patients in particular. Release

Biotech News

 @FierceBiotech: Alzheimers investigators see fresh sign of solanezumab success in $LLY study. More | Follow @FierceBiotech

 @JohnCFierce: Biotech companies out there. You have any bad news to report? Do it now. Take advantage of the perfect storm to confess your sins quietly. | Follow @JohnCFierce

 @RyanMFierce: Focusing on hoped-for launch of tivozanib, $AVEO is axing 45 jobs or 17% of workers, eliminating 30 openings. More | Follow @RyanMFierce

> Cigarette maker Philip Morris rolls vaccine interests into China. Story

> Financial woes reduce AstraZeneca's industry profile. Item

> Theratechnologies once again tries to slash its way to breakeven point. Article

Pharma News

@FiercePharma: Korean pharma stocks are riding an updraft of M&A speculation. Keunwha, Hondok way up ... anyone shopping? More | Follow @FiercePharma

> Boehringer Ingelheim bets bigger on respiratory drugs. Story

> Bayer adds vitamin maker Schiff to buyout tally with $1.2B deal. News

> Patheon nabs Mexican beachhead with $255M Banner buyout. Report

Pharma Manufacturing News

> Boehringer again doubling capacity at inhaler plant. Report

> Patheon will pick up four plants with Banner buyout. News

> Congressional report calls for FDA to regulate large compounders. Article

> Drugmakers close plants ahead in face of Hurricane Sandy. Item

Biotech Research News

> Wisconsin company to provide stem cells for NIH research. Story

> Roche drug, microRNA treatment conquered head and neck cancer cells. News

> Baker's yeast yields possible Lou Gehrig's disease drug target. Article

> Duke team builds viable cartilage from induced pluripotent stem cells. Report

Suggested Articles

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.

A decade-long study found that patients with early breast cancer may be spared radiation procedures that span the whole breast.